All section Close
Image Credit: NDTV (Representational)
India To Test Four Ayurvedic Drugs For COVID-19 Treatment In A Week: Minister
Writer: Sumanti Sen
Sumanti Sen is an English Literature graduate who believes "there's just one kind of folks. Folks.".
India, 15 May 2020 11:19 AM GMT | Updated 15 May 2020 11:35 AM GMT
Editor : Shweta Kothari |
A broadcast turned digital journalist, Shweta Kothari heads the newsroom at The Logical Indian. She has previously worked with CNBC and NewsX as a news anchor and senior correspondent. Shweta holds a masters degree in journalism from the university of Sussex, UK and started her career with work placement with BBC in Scotland.
Creatives : Abhishek M |
" An engineer by profession, Abhishek is the creative producer of the team, graphic designing is his passion and travelling his get away. In more ways than one, he makes the content visually appealing."
These four formulations include Ashwagandha, Yashtimadhu (Mulethi), Guduchi Pippali (Giloy), and AYUSH-64, which was initially created to treat malaria.
The AYUSH (Ayurveda, Yoga, Unani, Siddha, and Homeopathy) Ministry and the CSIR (Council of Scientific and Industrial Research) are working on four traditional medicine formulations to treat coronavirus infection. Trials for the same will start within a week.
These four formulations include Ashwagandha, Yashtimadhu (Mulethi), Guduchi Pippali (Giloy), and AYUSH-64, which was initially created to treat malaria, NDTV reported.
"The @moayush & the @CSIR_IND are working together on validating four Ayush formulations against #COVID19Pandemic and the trials will start within one week. These formulations will be tried as an add-on therapy and standard care for COVID-19 patients." He later tweeted, "I am sure and quite hopeful that, our traditional medicinal system will show the way to overcome this Pandemics," Union Minister of State for AYUSH, Shripad Y Naik tweeted.
The @moayush & the @CSIR_IND are working together on validating four Ayush formulations against #COVID19Pandemic and the trials will start within one week. These formulations will be tried as an add-on therapy and standard care for COVID-19 patients.
— Shripad Y. Naik (@shripadynaik) May 14, 2020
A randomized controlled clinical trial will be conducted by the government in order to assess the efficacy of Ayurvedic drug Ashwagandha as a preventive intervention. It will be a joint initiative of the ministers of AYUSH, health, science, and technology through CSIR with technical support from the Indian Council of Medical Research (ICMR).
"There has been a long-felt need for many of Ayurvedic formulations. We should actually try from the modern science perspective so that we get the acceptability." He further adds that Ayurveda is based on thousands of years of clinical practices that have been followed, so we trust Ayurveda. We are not able to show the mechanism of action like modern medicine does. Ayurvedic practices have existed much before modern medicine practices came. Therefore, it is important that we validate some of the Ayurvedic principles. So, the time is absolutely right that in the fight against coronavirus we try some Ayurvedic formulations," CSIR Director-General Shekhar Mande had said on May 7.
Reportedly, CSIR Director-General Shekhar Mande and the AYUSH Secretary Vaidya Rajesh Kotecha said on Wednesday, may 13, that the result will come within three months.
Also Read: US Biotechnology Company Moderna Receives FDA 'Fast Track' Designation For COVID-19 Vaccine
Must Reads
We are an independent and public-spirited digital media platform for Indian millennials. We report news and issues that matter as well as give you the opportunity to take action.
